Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats

Erkan Gumus; Ahmet Sevki Taskıran; Hacer Aybike Toptas; Özge Güney; Rukiye Kutlu; Handan Gunes; Ercan Ozdemir; Gokhan Arslan

doi:10.7197/223.v39i32356.369027

EN TR

Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats

Öz

Objective: Epilepsy is a short-term paroxysmal disturbances of brain functions observed between sudden, abnormal and hypersynchronization discharges and seizures of a group of neurons in the central nervous system. The nonsteroidal anti-inflammatory tenoxicam is chemical agent that selectively inhibits type 2 cyclooxygenase (COX2), which converts arachidonic acid to prostaglandins (PGs). The aim of this study was to investigate the effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole on epileptic seizures.
Method: Eighteen Wistar Albino male rats (220±20 g) were divided into three groups: control (n=6), 10 mg/kg/day tenoxicam (n=6) and, 20 mg/kg/day tenoxicam (n=6). Tenoxicam was administered intramuscularly for ten days. On the tenth day, pentylenetetrazol (PTZ) was injected intraperitoneally at 70 mg/kg after 45 minutes of drug administration and the animals were observed for 30 min. Stages were determined according to the Racine seizure scale (RC) and the first myoclonic jerk time (FMJ) was recorded in seconds. After completing procedure, whole brain tissues were removed and stained with toluidine blue stain. The number of dark neurons with chromatin aggregation in hypocampal CA1 and dentate gyrus (DG) was determined as percentage.
Results: Epileptic behavior were evaluated according to the RC, 10 mg/kg of tenoxicam significantly reduced the seizure stage compared to the control (p<0,05). In addition, 10 mg/kg tenoxicam significantly increased the FMJ compared to the control (p<0,05). According to the histopathological findings, neuronal damage was increased in CA1 region of 20 mg/kg of tenoxicam group compared to control, whereas neuronal damage was reduced significantly in the dentate gyrus of 10 mg/kg and 20 mg/kg of tenoxicam groups (p<0,05).

Conclusions: This study shows that dose-dependent administration of tenoxicam might have a potential to reduce epileptic seizures and post-seizure neuron damage.

Anahtar Kelimeler

Epilepsy,cyclooxygenase-2 inhibitor,tenoxicam,pentylenetetrazole

Siklooksijenaz-2 inhibitörü tenoksikam'ın pentilentetrazol ile oluşturulan epileptik nöbetler üzerine etkisi

Öz

Amaç: Epilepsi merkezi sinir sisteminde bir grup nöronun ani, anormal ve hipersenkronize deşarjları ile nöbetler halinde gözlenen beyin fonksiyonlarının kısa süreli paroksimal rahatsızlığı olarak tanımlanır. Nonsteroid anti inflamatuarlardan olan tenoksikam araşidonik asidi prostaglandinlere dönüştüren tip 2 siklooksijenaz (COX2) enzimini selektif olarak inhibe eden kimyasal bir ajandır. Bu çalışmanın amacı siklooksijenaz-2 inhibitörü tenoksikam'ın pentilentetrazol ile oluşturulan epileptik nöbetlere üzerine etkisini araştırmaktır.

Yöntem: Çalışmamızda 18 tane 220-240 gr Wistar Albino erkek sıçan kullanılmıştır. Hayvanlar kontrol (n=6), 10 mg/kg/gün tenoksikam (n=6) ve 20 mg/kg/gün tenoksikam (n=6) olmak üzere üç gruba ayrıldı. On gün süre ile kontrol grubuna çözücü ve diğer iki gruba belirtilen dozlarda tenoksikam intramusküler olarak uygulandı. Onuncu gün ilaç uygulamalarından 45 dk sonra pentilentetrazol (PTZ) 70 mg/kg intraperitoneal olarak enjekte edildi. Hayvanlar 30 dk boyunca gözlemlendi. Racine nöbet skalasına göre evreleri belirlendi ve ilk miyoklonik jerk zamanı (FMJ) saniye olarak kaydedildi. İşlem bitiminden sonra hayvanların beyin dokuları alındı. Beyin dokuları rutin histolojik takip sonrası toluidin blue boyası ile boyanandı. Hipokampüste CA1 ve dentat girus bölgelerinde nöronal hasarı gösteren ‘Dark nöron’ sayıları yüzde olarak belirlendi.

Bulgular: Epileptik davranış sonuçları Racine nöbet skalasına (RC) göre değerlendirildiğinde, 10 mg/kg tenoksikam kontrole göre nöbet evresini anlamlı olarak azalttı (p<0,05). Ayrıca 10 mg/kg tenoksikam kontrole göre ilk miyoklonik jerk zamanını anlamlı olarak arttırdı (p<0,05). Histopatolojik olarak gruplar değerlendirildiğinde, CA1 bölgesinde 20 mg/kg tenoksikam kontrole göre nöronal hasarı arttıdığı, buna karsışık dentat girus bölgelesinde 10 mg/kg ve 20 mg/kg tenoksikam nöronal hasarı anlamlı olarak azalttı (p<0,05).

Sonuç: Bu çalışma tenoksikam uygulamasının epileptik nöbetleri ve nöbet sonrası nöron hasarını doz bağımlı olarak azaltabileceğini göstermektedir.

Anahtar Kelimeler

Epilepsi,Siklooksijenaz -2 inhibitörü,tenoksikam,pentilentetrazol

Kaynakça

1. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia. 2005; 46: 1724-43.
2. Vezzani A, Baram TZ. New roles for interleukin-1 Beta in the mechanisms of epilepsy. Epilepsy Curr 2007; 7: 45-50.
3. Choi J, Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med J. 2008; 49: 1-18.
4. Takemiya T, Matsumura K, Yamagata K. Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochem Int 2007; 51: 112-20.
5. Rijkers K, Majoie HJ, Hoogland G, Kenis G, De Baets M, Vles JS. The role of interleukin-1 in seizures and epilepsy: a critical review. Exp Neurol 2009; 216: 258-71.
6. Zhang J, Goorha S, Raghow R, Ballou LR. The tissue-specific, compensatory expression of cyclooxygenase-1 and -2 in transgenic mice. Prostaglandins Other Lipid Mediat 2002; 67: 121-35.
7. Cole-Edwards KK, Bazan NG. Lipid signaling in experimental epilepsy. Neurochem Res 2005; 30: 847-53.
8. Kulkarni SK, Dhir A. Cyclooxygenase in epilepsy: from perception to application. Drugs Today 2009; 45: 135-54.

9. Polascheck N, Bankstahl M, Löscher W. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp Neurol 2010; 224: 219-33.
10. Van Antwerpen P, Neve J. In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide families. Eur J Pharmacol 2004; 496: 55-61.
11. Naziroğlu M, Uğuz AC, Gokçimen A, Bülbül M, Karatopuk DU, Türker Y, Cerçi C. Tenoxicam modulates antioxidant redox system and lipid peroxidation in rat brain. Neurochem Res 2008; 33: 1832-7.
12. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972; 32: 281-94.
13. Uyanikgil Y1,2, Özkeşkek K3, Çavuşoğlu T1,2, Solmaz V4, Tümer MK5, Erbas O6 Positive effects of ceftriaxone on pentylenetetrazol-induced convulsion model in rats. Int J Neurosci 2016;126: 70-5.
14. Okada K, Yuhi T, Tsuji S, Yamashita U. Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible El mice was increased after seizure. Brain Res 2001; 894: 332-5.
15. Tu B, Bazan NG. Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp Neurol 2003; 179: 167-75.
16. Kawaguchi K, Hickey RW, Rose ME, Zhu L, Chen J, Graham SH. Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus. Brain Res 2005; 1050: 130-7.
17. Dhir A, Naidu PS, Kulkarni SK. Effect of cyclooxygenase-2 (COX-2) inhibitors in various animal models (bicuculline, picrotoxin, maximal electroshock-induced convulsions) of epilepsy with possible mechanism of action. Indian J Exp Biol 2006; 44: 286-91.
18. Desjardins P, Sauvageau A, Bouthillier A, Navarro D, Hazell AS, Rose C, Butterworth RF. Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis. Neurochem Int 2003; 42: 299-303.
19. Du Y, Kemper T, Qiu J, Jiang J. Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus. Expert Rev Neurother 2016; 16: 123-30
20. Kunz T, Oliw EH. The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur J Neurosci 2001; 13: 569-75.
21. Kawaguchi K, Hickey RW, Rose ME, Zhu L, Chen J, Graham SH. Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus. Brain Res 2005; 1050:130-7.
22. Holtman L, van Vliet EA, van Schaik R, Queiroz CM, Aronica E, Gorter JA. Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Res 2009; 84: 56-66.
23. Baik EJ, Kim EJ, Lee SH, Moon C. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res 1999; 843: 118-29.
24. Polascheck N, Bankstahl M, Löscher W. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp Neurol 2010; 224: 219-33.
25. Karimzadeh F., Hosseini M., Mangeng D. Anticonvulsant and neuroprotective effects of Pimpinella anisum in rat brain. BMC Complement Altern Med 2012; 12: 76.
26. Seghatoleslam M, Alipour F, Shafieian R, Hassanzadeh Z, Edalatmanesh MA, Sadeghnia HR, Hosseini M. The effects of Nigella sativa on neural damage after pentylenetetrazole induced seizures in rats. J Tradit Complement Med 2015; 6: 262-8.
27. Baracskay P, Szepesi Z, Orbán G, Juhász G, Czurkó A. Generalization of seizures parallels the formation of "dark" neurons in the hippocampus and pontine reticular formation after focal-cortical application of 4-aminopyridine (4-AP) in the rat. Brain Res 2008; 1228: 217-28.
28. Mansouri S, Ataei ML, Hosseini M, Bideskan AR. Tamoxifen mimics the effects of endogenous ovarian hormones on repeated seizures induced by pentylenetetrazole in rats. Exp Neurobiol 201; 22: 116-23.
29. Kherani ZS, Auer RN. Pharmacologic analysis of the mechanism of dark neuron production in cerebral cortex. Acta Neuropathol 2008; 116:447-52.
30. Pitkanen A., Tuunanen J., Kalviainen R., Partanen K., Salmenpera T. Amygdala damage in experimental and human temporal lobe epilepsy. Epilepsy Res 1998; 32: 233–253.
31. Salmenpera T., Kalviainen R., Partanen K., Pitkanen A. Hippocampal and amygdaloid damage in partial epilepsy: a cross-sectional MRI study of 241 patients. Epilepsy Res 2001; 46: 69-82.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Erkan Gumus

Ahmet Sevki Taskıran

Hacer Aybike Toptas

Özge Güney

Rukiye Kutlu

Handan Gunes

Ercan Ozdemir

Gokhan Arslan

Yayımlanma Tarihi

18 Aralık 2017

Gönderilme Tarihi

17 Temmuz 2017

Kabul Tarihi

24 Ekim 2017

Yayımlandığı Sayı

Yıl 2017 Cilt: 39 Sayı: 4

DOI

https://doi.org/10.7197/223.v39i32356.369027

IZ

https://izlik.org/JA69GH93JF

Kaynak Göster

RIS / Bibtex

APA

Gumus, E., Taskıran, A. S., Toptas, H. A., Güney, Ö., Kutlu, R., Gunes, H., Ozdemir, E., & Arslan, G. (2017). Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats. Cumhuriyet Medical Journal, 39(4), 652-658. https://doi.org/10.7197/223.v39i32356.369027

AMA

1.Gumus E, Taskıran AS, Toptas HA, vd. Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats. CMJ. 2017;39(4):652-658. doi:10.7197/223.v39i32356.369027

Chicago

Gumus, Erkan, Ahmet Sevki Taskıran, Hacer Aybike Toptas, vd. 2017. “Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats”. Cumhuriyet Medical Journal 39 (4): 652-58. https://doi.org/10.7197/223.v39i32356.369027.

EndNote

Gumus E, Taskıran AS, Toptas HA, Güney Ö, Kutlu R, Gunes H, Ozdemir E, Arslan G (01 Aralık 2017) Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats. Cumhuriyet Medical Journal 39 4 652–658.

IEEE

[1]E. Gumus vd., “Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats”, CMJ, c. 39, sy 4, ss. 652–658, Ara. 2017, doi: 10.7197/223.v39i32356.369027.

ISNAD

Gumus, Erkan - Taskıran, Ahmet Sevki - Toptas, Hacer Aybike - Güney, Özge - Kutlu, Rukiye - Gunes, Handan - Ozdemir, Ercan - Arslan, Gokhan. “Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats”. Cumhuriyet Medical Journal 39/4 (01 Aralık 2017): 652-658. https://doi.org/10.7197/223.v39i32356.369027.

JAMA

1.Gumus E, Taskıran AS, Toptas HA, Güney Ö, Kutlu R, Gunes H, Ozdemir E, Arslan G. Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats. CMJ. 2017;39:652–658.

MLA

Gumus, Erkan, vd. “Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats”. Cumhuriyet Medical Journal, c. 39, sy 4, Aralık 2017, ss. 652-8, doi:10.7197/223.v39i32356.369027.

Vancouver

1.Erkan Gumus, Ahmet Sevki Taskıran, Hacer Aybike Toptas, Özge Güney, Rukiye Kutlu, Handan Gunes, Ercan Ozdemir, Gokhan Arslan. Effect of the cyclooxygenase-2 inhibitor tenoxicam on pentylenetetrazole-induced epileptic seizures in rats. CMJ. 01 Aralık 2017;39(4):652-8. doi:10.7197/223.v39i32356.369027

Cited By

Wi-Fi decreases melatonin protective effect and increases hippocampal neuronal damage in pentylenetetrazole induced model seizures in rats

Pathophysiology

https://doi.org/10.1016/j.pathophys.2019.11.003

Metforminin tek başına veya valproik asit ile beraber farelerde pentilentetrazol ile indüklenen nöbetler üzerine koruyucu etkisi

Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi

https://doi.org/10.17517/ksutfd.914271